Sir,
We were interested to read the paper by Amitai et al. 1 reporting an association between congenital dislocation of the hip (CDH) and short maternal stature, based on a study of 33 consecutive cases and 54 controls (P<0-Ol). We have been interested in the aetiology of CDH for many years and have just completed a study of 455 infants with CDH born in the care of the university service in Bristol, so it was easy to scan our records to find out if our data supported this new observation.
Among the 455 infants with CDH born between 1970 and 1979 all but 10 cases were diagnosed in the neonatal period. Maternal height was available in 330 cases. We took as our controls randomly selected mothers of babies born in our hospital during the same period who did not have CDH. The maternal height of the two groups was then compared, first in 5-cm subgroups and then as in the Figure below; Necrotising enterocolitis in the very low birthweight infant Sir, Drayton et al.1 were so anxious to criticise our paper2 that they did not read it properly. All the 'missing' figures concerning the incidence of necrotising enterocolitis (NEC) in preterm infants with birthweight above 1500 g were given in the results section. 3 Regarding the age of onset of NEC and the duration of parenteral feeding recommended by us, in Wilson's series4 of 148 cases of NEC, 86 of whom were VLBW infants, the median age at onset was 7 days. Average age at onset in Kliegman's5 123 NEC patients (70% VLBW infants) was 12 days. It is true that the age at onset of NEC has an inverse relationship to the gestational age. This is the reason for our recommendation of at least a 3-weeks period of parenteral nutrition in infants weighing 1000 g and below at birth. If our colleagues from the Southmead Health District wish to carry on with parenteral nutrition beyond this period, all we do can is congratulate them.
Drayton et al. are concerned about biochemical and technical difficulties. During the last 3 years we have not noted any serious adverse effect which could be attributed to parenteral nutrition (nearly 300 infants), and we feel we have avoided many cases of NEC. We think this achievement is much more important than a possible theoretical gain-such as induction of gut hormone production by enteral feeding. 4 The response of our patient to ketoconazole indicates that it is an effective agent in the treatment of systemic candidiasis. It has the advantage of being well absorbed when given orally. Thus one is not faced with the problem of long-term intravenous therapy, a feature of particular importance in the neonate.
J HENSEY AND R W I COOKE
Department of Child Health, Liverpool Maternity Hospital, Oxford Street, Liverpool L7 7BN Electronmicroscopy in 'absence' of islets of Langerhans in a newborn infant Sir, In a previous report' we described the case history and histology at necropsy of a boy with congenital diabetes mellitus who died on the third day of life. His brother had died 8 years previously after a remarkably similar neonatal illness, but with no diagnosis established. Our patient weighed only 2-13 kg at term, was obviously wasted, and developed respiratory distress, although the chest x-ray film was normal. Blood gas analysis indicated a mild metabolic acidosis which increased during the next 24 hours despite administration of sodium bicarbonate. The urine contained large amounts of glucose and acetone, and the blood sugar at 36 hours was > 22 mmol/l. Despite intravenous fluids and insulin, he died suddenly from pulmonary haemorrhage at age 40 hours.
Studies at necropsy showed that the pancreas was externally normal but no recognisable islets of Langerhans could be found. There were a few lymphoid aggregates and occasional granular cells which might have been of endocrine origin, but these gave a negative staining reaction for o-and P-cells. 
